▲ BUY
5
/ 10
Conviction
$ Value
$36K
Shares
5,000
Price
$7
Filed
Sep 30
▶ Why this score? (5/10)
- ✓ Open market buy (+3)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Feinberg Peter
Title
—
CIK
0001870076
Roles
Director
Transaction Details
Transaction Date
2025-09-29
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
141,766
Filing Info
Feinberg Peter's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-12 | IMRX | ▲ | $87K ★ |
| 2026-01-01 | IMRX | A | $0 |
| 2025-10-03 | IMRX | ▲ | $50K |
| 2025-09-30 | IMRX | ▲ | $53K |
| 2025-09-29 | IMRX | ▲ | $36K |
| 2025-06-18 | IMRX | ▲ | $63K |
| 2025-06-13 | IMRX | A | $0 |
Other Insiders at IMRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Matushansky Igor
Chief Medical Officer
|
— | — | 2026-02-03 |
|
Bookman Michael
CHIEF LEGAL OFFICER, SECRETARY
|
— | — | 2026-02-03 |
|
Zeskind Benjamin J.
PRESIDENT AND CEO
|
— | — | 2026-02-03 |
|
Hall Brett Matthew
CHIEF SCIENTIFIC OFFICER
|
— | — | 2026-02-03 |
|
Morales Mallory
SVP Finance, CAO
|
— | — | 2026-02-03 |
|
Neufeld Leah R
CHIEF PEOPLE OFFICER
|
— | — | 2026-03-13 |
|
Brakewood Harold Eugene
Chief Business Officer
|
— | — | 2026-02-03 |